Abstract
A series of 2-thioxo-imidazolidin-4-one derivatives were synthesized and were characterized by IR, 1H NMR, 13C NMR, mass spectral data and elemental analysis. All compounds were tested for antifungal and antibacterial activity. Some of the compounds were found to exhibit promising antifungal activity. Molecular modeling investigations showed that the active compounds may interact at the active site of the fungal cytochrome P450- dependent sterol 14α- demethylase in the sterol biosynthesis pathway.
Keywords: 2-thioxo-imidazolidin-4-one, antifungal, antibacterial, molecular modeling, Aspergillus fumigatus, Candida tropicalis, ketoconazole, C. albicans, acetic acid, sterol
Medicinal Chemistry
Title:Synthesis, Antifungal Evaluation and Molecular Docking Studies on 2- thioxoimidazolidin-4-one Derivatives
Volume: 9 Issue: 3
Author(s): Sudha Vengurlekar, Rajesh Sharma and Piyush Trivedi
Affiliation:
Keywords: 2-thioxo-imidazolidin-4-one, antifungal, antibacterial, molecular modeling, Aspergillus fumigatus, Candida tropicalis, ketoconazole, C. albicans, acetic acid, sterol
Abstract: A series of 2-thioxo-imidazolidin-4-one derivatives were synthesized and were characterized by IR, 1H NMR, 13C NMR, mass spectral data and elemental analysis. All compounds were tested for antifungal and antibacterial activity. Some of the compounds were found to exhibit promising antifungal activity. Molecular modeling investigations showed that the active compounds may interact at the active site of the fungal cytochrome P450- dependent sterol 14α- demethylase in the sterol biosynthesis pathway.
Export Options
About this article
Cite this article as:
Vengurlekar Sudha, Sharma Rajesh and Trivedi Piyush, Synthesis, Antifungal Evaluation and Molecular Docking Studies on 2- thioxoimidazolidin-4-one Derivatives, Medicinal Chemistry 2013; 9 (3) . https://dx.doi.org/10.2174/1573406411309030016
DOI https://dx.doi.org/10.2174/1573406411309030016 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer
Current Pharmaceutical Design Immunoproteasome-Selective Inhibitors: A Promising Strategy to Treat Hematologic Malignancies, Autoimmune and Inflammatory Diseases
Current Medicinal Chemistry Evidences and Opinions for Adjuvant Therapy in Pancreatic Cancer
Current Drug Targets Is Going for Cure in CML Targeting Aberrant Glycogen Synthase Kinase 3β?
Current Drug Targets Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review
Current Drug Targets Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs
Current Medicinal Chemistry Type I Interferons: Ancient Peptides with Still Under-Discovered Anti-Cancer Properties
Protein & Peptide Letters Identifying Molecular Biomarker for the Lung Squamous Cell Carcinoma by Integrating Multifactorial Data
Current Bioinformatics The Effect of Casein Kinase 2 Inhibition on three Leukemic Cell Lines
Current Drug Therapy Editorial [Hot Topic: Molecular Tools in Cancer Diagnosis and Therapy Guest Editor: Riyaz Basha]
Current Medicinal Chemistry Phosphorylation-Specific Prolyl Isomerase Pin1 as a new Diagnostic and Therapeutic Target for Cancer
Current Cancer Drug Targets FK506 Binding Proteins as Targets in Anticancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Vitamins in the Prevention or Delay of Cognitive Disability of Aging
Current Aging Science MicroRNAs and Aging: Biomarkers or Therapeutic Targets?
Current Aging Science Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Current Pharmaceutical Design Investigation of the Pharmacokinetics of the ABCG2 Transporter Inhibitor Ko134 in Mice by a Newly Developed and Validated HPLC Method
Current Pharmaceutical Analysis Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment
Current Clinical Pharmacology Emerging Family of Protein-protein Interaction Inhibitors Targeting PD-1 Checkpoint Pathway
Current Cancer Therapy Reviews PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance
Current Cancer Drug Targets Toll-Like Receptors in Human Multiple Myeloma: New Insight into Inflammation-Related Pathogenesis
Current Molecular Medicine